Gland Pharma Ltd share price logo

Gland Pharma Ltd

NSE: GLAND

BSE: 543245

Mid Cap

Pharma Sector

₹2334.00

+3.00

(+0.13%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Block Trade Alert

Gland Pharma recorded an NSE block trade of approximately 129,196 shares valued at Rs. 30.06 crore at Rs. 2326.50 per share.

Gland Pharma Stock Performance

as on May 22, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,307.20
    ₹2,363.50
    downward going graph

    1.15%

    Downside

    1.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,452.20
    ₹2,363.50
    downward going graph

    37.78%

    Downside

    1.26%

    Upside

    downward going graph

Gland Pharma share price movements today

Previous Close
₹2,331.00
Open
₹2,353.50
Volume
8.64L
Upper Circuit
₹2,797.20
Lower Circuit
₹1,864.80
Day's Low - High
₹2,307.20 - ₹2,363.50
52 Week Low - High
₹1,452.20 - ₹2,363.50

Gland Pharma Historical Returns

1 Month Return
+ 29.46 %
3 Month Return
+ 29.3 %
1 Year Return
+ 50.72 %
3 Year Return
+ 160.87 %
5 Year Return
-25.65 %

Gland Pharma Fundamentals

as on May 22, 2026 at 4:01 pm IST

Market Cap

₹38,404.72 Cr

Return on Equity (ROE)

11.62

PE Ratio (TTM)

37.38

Return on capital employed (ROCE)

15.83

Industry PE ratio

46.14

Beta (LTM)

0.76

P/B Ratio

2.69

Dividend Yield

1.13

PEG Ratio

1.87

Quarterly Earnings Growth YOY

96.57

EPS (TTM)

42.4

Sector

Pharmaceuticals

Book Value

555.4

Gland Pharma Stock Valuation

as on May 22, 2026 at 4:01 pm IST

Gland Pharma in the last 5 years

  • Overview

  • Trends

Lowest (18.84x)

May 22, 2023

Today (37.38x)

May 21, 2026

Industry (46.14x)

May 21, 2026

Highest (67.14x)

August 12, 2021

LowHigh

Today’s Price to Earnings Ratio: 37.38x

Gland Pharma Technical Analysis

Track how Gland Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish11
Bullish2
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-3.44
Bullish
CCI (20)
181.06
Bearish
RSI (14)
33.97
Neutral
Momentum (10)
-2
Bullish
ADI (14)
49.62
Bearish
Ultimate Oscillator (7,14,28)
32.21
Neutral

Moving Averages

Name

Value

Action

SMA (20)
2327.47
Bearish
EMA (20)
2328.61
Bearish
VWMA (20)
2326.69
Bearish
SMA (50)
2337.54
Bearish
EMA (50)
2334.56
Bearish
SMA (200)
2345.21
Bearish
EMA (200)
2340.62
Bearish
KAMA (200)
2333.87
Bearish
DEMA (200)
2343.9
Bearish

Gland Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gland Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Gland Pharma Ltd image
Gland Pharma Ltd
BUY38,404.72-5.13%0.536985,616
Divis Laboratories Ltd image
Divis Laboratories Ltd
BUY1,82,058.3513.48%0.502,1919,360
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,51,258.0445.77%0.661,91111,516
Biocon Ltd image
Biocon Ltd
BUY69,836.812.47%0.781,42915,261
Cipla Ltd image
Cipla Ltd
BUY1,13,245.5610.11%0.515,29127,547
See all

Market expectation of Gland Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

60.00%

Buy

13.33%

Hold

26.67%

Sell

Gland Pharma Stock’s Investor Sentiment and Interest

Investment in Gland Pharma Ltd Shares on INDmoney has grown by 1850.75% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:1850.75% versus previous 30 day period

Search interest for Gland Pharma Ltd Stock has increased by 295% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:295% versus previous 30 day period

Gland Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
1,208.69
1,373.42
1,545.16
1,537.45
1,401.71
1,405.83
1,384.05
1,424.91
1,505.62
1,486.88
1,695.36
1,742.79
Other Income
37.54
53.16
37.39
42.15
51.43
59.66
58.49
44.03
57.53
84.16
63.17
111.47
Total Income
1,246.24
1,426.58
1,582.55
1,579.6
1,453.14
1,465.49
1,442.55
1,468.94
1,563.15
1,571.04
1,758.54
1,854.26
Expenses
914.74
1,049.35
1,188.77
1,178.8
1,137.31
1,108.78
1,024.1
1,077.39
1,137.86
1,172.99
1,284.83
1,229.77
Operating Profit
293.95
324.07
356.39
358.65
264.4
297.05
359.95
347.52
367.76
313.89
410.53
513.02
Operating Profit Margin %
24.32%
23.6%
23.06%
23.33%
18.86%
21.13%
26.01%
24.39%
24.43%
21.11%
24.21%
29.44%
Profit Before Interest, Tax and Depreciation
331.5
377.23
393.78
400.8
315.82
356.72
418.45
391.54
425.29
398.05
473.7
624.49
Interest
4.92
6.05
5.28
9.96
5.62
6.11
22.82
7.45
11.5
7.82
3.93
10.03
Depreciation
65.32
81.3
105.34
92.61
91.96
93.83
96.33
95.76
101.05
106.31
107.65
108.66
Profit Before Tax
261.26
289.88
283.16
298.23
218.24
256.78
299.3
288.33
312.74
283.92
362.12
505.8
Tax Paid
67.16
95.8
91.31
105.81
74.48
93.24
94.61
101.79
97.26
100.23
100.65
139.12
Profit After Tax
194.1
194.08
191.86
192.42
143.76
163.53
204.69
186.54
215.48
183.68
261.48
366.68
Total Net profit including share of profit / Loss from associate company
194.1
194.08
191.86
192.42
143.76
163.53
204.69
186.54
215.48
183.68
261.48
366.68
EPS
11.79
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87
22.26
Actual EPS
11.79
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87
22.26
Adjusted EPS
11.79
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87
22.26
Diluted EPS
11.78
11.78
11.65
11.68
8.73
9.93
12.42
11.32
13.08
11.15
15.87
22.23

Gland Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
2,633.24
3,462.88
4,400.71
3,624.6
5,664.72
5,616.5
6,430.65
Other Income
139.17
134.78
223.94
240.46
170.24
213.61
316.33
Total Income
2,772.41
3,597.65
4,624.65
3,865.06
5,834.96
5,830.11
6,746.98
Expenses
1,677.77
2,160.65
2,890.56
2,656.3
4,331.65
4,347.58
4,825.45
Operating Profit
955.47
1,302.23
1,510.15
968.3
1,333.07
1,268.92
1,605.2
Operating Profit Margin %
36.28%
37.61%
34.32%
26.71%
23.53%
22.59%
24.96%
Profit Before Interest, Tax and Depreciation
1,094.64
1,437
1,734.09
1,208.77
1,503.31
1,482.53
1,921.53
Interest
7.18
3.41
5.24
7.45
26.2
42
33.28
Depreciation
94.59
98.78
110.3
146.74
344.57
377.87
423.67
Profit Before Tax
992.87
1,334.81
1,618.55
1,054.58
1,132.54
1,062.66
1,464.58
Tax Paid
220.01
337.85
406.89
273.54
360.08
364.13
437.26
Profit After Tax
772.86
996.96
1,211.66
781.04
772.46
698.53
1,027.32
Total Net profit including share of profit / Loss from associate company
772.86
996.96
1,211.66
781.04
772.46
698.53
1,027.32
EPS
49.88
63.07
73.81
47.44
46.9
42.4
62.35
Actual EPS
49.88
63.07
73.81
47.44
46.9
42.4
62.35
Adjusted EPS
49.88
63.07
73.81
47.44
46.9
42.4
62.35
Diluted EPS
49.88
62.99
73.64
47.43
46.89
42.4
62.28

Gland Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
700.94
604.93
790.77
363.97
996.8
914.73
Cash Flow from Investing Activities
-760.96
-1,520.42
-999.3
1,211.18
-1,749.19
1,717.86
Cash Flow from Financing Activities
-6.87
1,238.46
34.89
14.92
-799.41
-433.48
Net Cash Flow
-66.91
322.97
-173.64
1,590.08
-1,551.81
2,199.12

Gland Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
57.86%
57.86%
57.86%
57.86%
51.83%
51.83%
51.83%
51.83%
51.83%
51.83%
51.83%
51.83%
DII
23.38%
22.45%
23.14%
25.23%
32.83%
35.37%
34.8%
33.27%
32.85%
32.64%
32.98%
33.35%
FII
0%
4.91%
0%
3.59%
6.88%
4.47%
5.04%
6.9%
7.39%
7.91%
7.58%
7.3%
Public
15.96%
14.78%
13.93%
13.32%
8.45%
8.32%
8.33%
7.99%
7.93%
7.63%
7.61%
7.52%
Total Outstanding Shares
16,47,00,823
16,47,00,823
16,47,01,923
16,47,10,523
16,47,51,723
16,47,51,723
16,47,51,723
16,47,56,423
16,47,56,423
16,47,56,423
16,47,56,423
16,47,56,423
Total Shareholders
1,81,747
1,61,627
1,36,021
1,22,375
1,22,665
1,22,358
1,21,075
1,13,788
1,10,671
97,151
94,578
91,500

Mutual Funds that own Gland Pharma Stock

Check out the Mutual Funds with significant holdings in Gland Pharma.

Gland Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Gland Pharma.

  • Gland Pharma Ltd Earnings Results

    Gland Pharma Ltd’s net profit jumped 96.57% since last year same period to ₹366.68Cr in the Q4 2025-2026. On a quarterly growth basis, Gland Pharma Ltd has generated 40.23% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Gland Pharma Ltd Dividends May,2025

    In the quarter ending March 2025, Gland Pharma Ltd has declared dividend of ₹18.00 per share on 20 May 2025 - translating a dividend yield of 1.63%.

    Read More about Dividends

Indices Featuring Gland Pharma Stock

Check stock indices that include Gland Pharma.

Nifty MNC

₹31,955.70

0.25 (▲79.55%)

NIFTY PHARMA

₹24,573.95

-1.27 (▲316.95%)

Nifty Smallcap 250

₹16,775.30

-0.13 (▲21.00%)

BSE Healthcare

₹47,267.53

-1.23 (▲589.53%)

BSE 500

₹35,413.94

0.21 (▲73.63%)

S&P BSE 250 LargeMidCap

₹10,517.28

0.26 (▲27.34%)

Nifty 500

₹22,651.30

0.21 (▲48.45%)

Nifty Small 100

₹17,956.20

-0.15 (▲26.85%)

S&P BSE 400 MidSmallCap

₹12,125.40

-0.01 (▲1.27%)

Nifty Smallcap 50

₹8,836.70

-0.24 (▲21.60%)

Nifty MidSmallcap 400

₹20,387.65

0.03 (▲6.65%)

S&P BSE 150 MidCap

₹16,374.34

0.11 (▲18.35%)

Insights on Gland Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 31.42% to 31.78% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, GLAND has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 1.44K Cr → 1.85K Cr (in ₹), with an average increase of 4.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GLAND stock has moved up by 24.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 183.68 Cr → 366.68 Cr (in ₹), with an average increase of 29.2% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.83% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 167.6% return, outperforming this stock by 6.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.61% to 7.52% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.58% to 7.30% in Mar 2026 quarter

About Gland Pharma Ltd

Gland Pharma Ltd is an Indian pharmaceutical company that was founded in 1978. The company is headquartered in Hyderabad and specializes in the development and manufacture of injectable drugs and active pharmaceutical ingredients (APIs). It is one of the largest independent companies in the world that provides high-quality, cost-effective injectable products.

Gland Pharma's operations include the development, manufacture, and marketing of a wide range of injectable drugs and active pharmaceutical ingredients. The company's product portfolio includes antibiotics, anti-emetics, anti-diabetics, anti-epileptics, and other therapeutic categories. Its top products include cephalosporins, penicillins, and other injectable antibiotics.

Gland Pharma is well known for its popular brands, such as Cephalosporin, Penicillin, and Amikacin. These brands have been widely used in hospitals and clinics across India, as well as in other countries. In addition, the company has developed and launched a wide range of generic and branded injectables, including Cefazolin, Cefuroxime, and Amikacin.

Revenue: ₹1,742.79Cr as on March 2026 (Q4 FY26)
Net Profit: ₹366.68Cr as on March 2026 (Q4 FY26)
Listing date: 20 Nov, 2020
Chairperson Name: Yiu Kwan Stanley Lau
OrganisationGland Pharma Ltd
IndustryPharmaceuticals
CEOYiu Kwan Stanley Lau
E-voting on sharesClick here to vote

FAQs

What is Gland Pharma share price today?

Gland Pharma share price today stands at ₹2334 as on at the close of the market. Gland Pharma share today touched a day high of ₹2363.5 and a low of ₹2307.2.

What is the 52 week high and 52 week low range for Gland Pharma share?

Gland Pharma touched a 52 week high of ₹2363.5 and a 52 week low of ₹1452.2. Gland Pharma share price today i.e. is closed at ₹2334, which is -1.25% down from its 52 week high and 60.72% up from its 52 week low.

What is Gland Pharma's market capitalisation today?

Gland Pharma market capitalisation is ₹38,404.72 Cr as on .

How to buy Gland Pharma shares?

To buy Gland Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GLAND or Gland Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Gland Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Gland Pharma trading volume today?

Gland Pharma trading volume is 8.64L as on . This means that 8.64L shares of Gland Pharma were bought and sold on the stock market during today's trading session.